Extract: Charter Amended/Restated (Plain English Desc) from a 8-K on 06/07/2021   Download
SEC Document
SEC Filing

On June 4, 2021, REGENXBIO Inc. (the “Company”) held its 2021 annual meeting of stockholders (the “Annual Meeting”), at which stockholders approved an amendment to the Company’s Restated Certificate of Incorporation to provide in Article V, Section F that, unless the Company consents in writing to the selection of an alternative forum, the federal district courts of the United States of America shall, to the fullest extent permitted by law, be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933, as amended (the “Federal Forum Selection Amendment”).

The Restated Certificate of Incorporation implementing the Federal Forum Selection Amendment was previously approved by the Company’s Board of Directors, subject to stockholder approval. The Company filed the Restated Certificate of Incorporation with the Secretary of State of the State of Delaware on June 4, 2021, with immediate effectiveness.